Sign in
Download Opera News App

DISEASE PREVENTION AND TREATMENT

Fosfomycin Not Noninferior to Comparators for Bacteremic UTI

Fosfomycin Not Noninferior to Comparators for Bacteremic UTI

FRIDAY, Jan. 14, 2022 -- For patients with bacteremic urinary tract infections (bUTIs) due to multidrug-resistant (MDR) Escherichia coli, fosfomycin is not noninferior to comparators, with an increased rate of adverse event-related discontinuations, according to a study published online Jan. 13 in JAMA Network Open. Jesús Sojo-Dorado, M.D., Ph.D., from the Universidad...

Read Full Story
Fosfomycin JAMA Network Jan Jesús Sojo-Dorado Spain Universidad de Sevilla

Top News

BUSINESS MANAGEMENT ANALYSIS

Caesarstone Announces Date for Fourth Quarter and Full Year 2021 Results

businesswire.com
Caesarstone Announces Date for Fourth Quarter and Full Year 2021 Results

BUSINESS MANAGEMENT ANALYSIS

Caesarstone Announces Date for Fourth Quarter and Full Year 2021 Results

businesswire.com

US POLITICS

Why not to expect a scorched earth fight over Breyer’s replacement

politico.com
Why not to expect a scorched earth fight over Breyer’s replacement

US POLITICS

Why not to expect a scorched earth fight over Breyer’s replacement

politico.com

comments

Load app to read more comments